是时候专注于改善艾滋病高流行地区的避孕方法组合了，不要再纠结那些无法回答的问题。 - Suppr

Suppr

超能文献

Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions.

作者信息

Jones Heidi E

机构信息

City University of New York (CUNY) School of Public Health, Hunter College.

出版信息

Contraception. 2014 Oct;90(4):357-9. doi: 10.1016/j.contraception.2014.05.014. Epub 2014 Jun 2.

DOI:10.1016/j.contraception.2014.05.014

PMID:24993486

Abstract

摘要

相似文献

Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions.

Contraception. 2014 Oct;90(4):357-9. doi: 10.1016/j.contraception.2014.05.014. Epub 2014 Jun 2.

Next steps for research on hormonal contraception and HIV.

Lancet. 2013 Nov 2;382(9903):1467-9. doi: 10.1016/S0140-6736(13)61420-8. Epub 2013 Jun 28.

Research on hormonal contraception and HIV.

Lancet. 2014 Jan 25;383(9914):303-4. doi: 10.1016/S0140-6736(14)60097-0.

Research on hormonal contraception and HIV.

Lancet. 2014 Jan 25;383(9914):304-5. doi: 10.1016/S0140-6736(14)60098-2.

Research on hormonal contraception and HIV.

Lancet. 2014 Jan 25;383(9914):305. doi: 10.1016/S0140-6736(14)60099-4.

Research on hormonal contraception and HIV - Authors' reply.

Lancet. 2014 Jan 25;383(9914):305-6. doi: 10.1016/S0140-6736(14)60100-8.

Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk.

Contraception. 2014 Dec;90(6):615-6. doi: 10.1016/j.contraception.2014.09.005. Epub 2014 Sep 16.

DMPA and HIV: why we need a trial.

Contraception. 2014 Oct;90(4):354-6. doi: 10.1016/j.contraception.2014.08.007.

Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception.

Am Fam Physician. 2011 Jan 1;83(1):35-6.

Comment on "hormonal contraception and HIV prevalence in four African countries".

Contraception. 2008 Oct;78(4):346; author reply 346-7. doi: 10.1016/j.contraception.2008.04.123. Epub 2008 Jul 22.

引用本文的文献

Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.

Pathogens. 2021 Sep 14;10(9):1192. doi: 10.3390/pathogens10091192.

Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

AIDS Res Hum Retroviruses. 2020 May;36(5):357-366. doi: 10.1089/AID.2019.0228. Epub 2020 Jan 22.

The Need for Policy Change Regarding Progestin-Only Injectable Contraceptives.

J Womens Health (Larchmt). 2019 Sep;28(9):1180-1184. doi: 10.1089/jwh.2018.7284. Epub 2018 Dec 21.

Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.

Contraception. 2015 Jun;91(6):480-7. doi: 10.1016/j.contraception.2015.02.004. Epub 2015 Feb 21.

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.

Lancet Infect Dis. 2015 Feb;15(2):181-9. doi: 10.1016/S1473-3099(14)71052-7. Epub 2015 Jan 9.

Broadening the debate over HIV and hormonal contraception.

Lancet Infect Dis. 2015 Feb;15(2):135-6. doi: 10.1016/S1473-3099(14)71076-X. Epub 2015 Jan 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions.

Contraception. 2014 Oct;90(4):357-9. doi: 10.1016/j.contraception.2014.05.014. Epub 2014 Jun 2.

Next steps for research on hormonal contraception and HIV.

Lancet. 2013 Nov 2;382(9903):1467-9. doi: 10.1016/S0140-6736(13)61420-8. Epub 2013 Jun 28.

Research on hormonal contraception and HIV.

Lancet. 2014 Jan 25;383(9914):303-4. doi: 10.1016/S0140-6736(14)60097-0.

Research on hormonal contraception and HIV.

Lancet. 2014 Jan 25;383(9914):304-5. doi: 10.1016/S0140-6736(14)60098-2.

Research on hormonal contraception and HIV.

Lancet. 2014 Jan 25;383(9914):305. doi: 10.1016/S0140-6736(14)60099-4.

Research on hormonal contraception and HIV - Authors' reply.

Lancet. 2014 Jan 25;383(9914):305-6. doi: 10.1016/S0140-6736(14)60100-8.

Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk.

Contraception. 2014 Dec;90(6):615-6. doi: 10.1016/j.contraception.2014.09.005. Epub 2014 Sep 16.

DMPA and HIV: why we need a trial.

Contraception. 2014 Oct;90(4):354-6. doi: 10.1016/j.contraception.2014.08.007.

Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception.

Am Fam Physician. 2011 Jan 1;83(1):35-6.

Comment on "hormonal contraception and HIV prevalence in four African countries".

Contraception. 2008 Oct;78(4):346; author reply 346-7. doi: 10.1016/j.contraception.2008.04.123. Epub 2008 Jul 22.

引用本文的文献

Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.

Pathogens. 2021 Sep 14;10(9):1192. doi: 10.3390/pathogens10091192.

Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

AIDS Res Hum Retroviruses. 2020 May;36(5):357-366. doi: 10.1089/AID.2019.0228. Epub 2020 Jan 22.

The Need for Policy Change Regarding Progestin-Only Injectable Contraceptives.

J Womens Health (Larchmt). 2019 Sep;28(9):1180-1184. doi: 10.1089/jwh.2018.7284. Epub 2018 Dec 21.

Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.

Contraception. 2015 Jun;91(6):480-7. doi: 10.1016/j.contraception.2015.02.004. Epub 2015 Feb 21.

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.

Lancet Infect Dis. 2015 Feb;15(2):181-9. doi: 10.1016/S1473-3099(14)71052-7. Epub 2015 Jan 9.

Broadening the debate over HIV and hormonal contraception.

Lancet Infect Dis. 2015 Feb;15(2):135-6. doi: 10.1016/S1473-3099(14)71076-X. Epub 2015 Jan 9.